Want to join the conversation?
$ENDP 2Q15 Q&A: David Amsellem from Piper Jaffray asked about color on generic pipeline & pending ANDAs? Rajiv said on Qualitest as we talked in context of Par transaction, we’ve a pipeline of roughly about 90 programs & of those substantial majority are ANDAs. Out of 90 programs, 60-70 ANDAs, we expect those to be approved & launched in 3-4 years.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.